Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NXGLthis companyNEXGEL, Inc.	$3.34	-4.21×	2.84×	1.11×	-7.28×	-153208.1%	39.5%	-29.3%	-26.3%	-67.3%	-42.0%	-10.9%	0.69×	-1.31×	-98.59×	1.47×	0.0%	1	-1.69	2	C
FEMYFemasys Inc.	$1.43	-1.23×	3.88×	9.93×	-1.15×	-203.0%	62.0%	-767.0%	-812.3%	-317.4%	-100.1%	-84.4%	0.8×	0.29×	-9.3×	4.53×	0.0%	1	-18.41	1	D+
HBIOHarvard Bioscience, Inc.	$9.07	-0.52×	2.16×	0.34×	-1.4×	-319.6%	53.0%	-0.7%	-65.5%	-412.8%	-1.0%	18.9%	3.22×	-0.77×	-0.13×	2.2×	0.0%	5	-2.53	1	D+
MLSSMilestone Scientific Inc.	$0.30	-3.9×	7.97×	2.5×	-4.05×	-405.4%	70.5%	-63.5%	-63.8%	-203.4%	-148.6%	-13.1%	0.36×	0.02×	-222.53×	1.81×	0.0%	3	-19.32	1	C-
MTVAMetaVia Inc.	$1.67	-1.15×	2.79×	0×	-0.37×	340.1%	0.0%	0.0%	0.0%	-243.3%	-21.6%	-105.6%	0.04×	0.78×	0×	1.93×	0.0%	0	-18.95	3	B
NXLNexalin Technology, Inc.	$1.43	-1.12×	2.44×	30.32×	-1.04×	-664.7%	79.7%	-2781.7%	-2725.8%	-219.4%	-223.9%	-54.2%	0×	0.08×	0×	4.85×	0.0%	3	-54.5	1	D+
Peer median	—	-1.15×	2.79×	2.5×	-1.15×	-319.6%	62.0%	-63.5%	-65.5%	-243.3%	-100.1%	-54.2%	0.36×	0.08×	-0.13×	2.2×	0.0%	3	-18.95	1	—